XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 100 | -83.3% | 0.00% | – |
| Q1 2022 | $1,000 | -95.8% | 600 | -97.1% | 0.00% | -100.0% |
| Q4 2021 | $24,000 | -44.2% | 20,600 | +100.1% | 0.00% | -50.0% |
| Q3 2021 | $43,000 | +95.5% | 10,293 | +391.8% | 0.00% | +100.0% |
| Q2 2021 | $22,000 | +450.0% | 2,093 | +161.6% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 800 | -20.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 1,000 | +11.1% | 0.00% | – |
| Q3 2020 | $8,000 | +300.0% | 900 | -18.2% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 1,100 | -15.4% | 0.00% | – |
| Q1 2020 | $3,000 | -83.3% | 1,300 | -34.0% | 0.00% | -100.0% |
| Q4 2019 | $18,000 | – | 1,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |